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Objective: To examine quality of life, work productivity, and health care resource use among 
employed adults ages 40–64 years with chronic obstructive pulmonary disease (COPD) in the 
United States.
Methods: Data from the 2009 National Health and Wellness Survey were used. All employed 
adults ages 40–64 years with or without a self-reported diagnosis of COPD were included in 
the study. Impact on quality of life (using the mental and physical component summary scores 
and health utilities from the Short Form-12v2), work productivity and activity impairment 
(using the Work Productivity and Activity Impairment questionnaire), and resource use were 
analyzed using regression modeling.
Results: There were 1112 employed adults with COPD versus 18,912 employed adults without 
COPD. After adjusting for demographics and patient characteristics, adults with COPD reported 
significantly lower mean levels of mental component summary (46.8 vs 48.5), physical component 
summary (45.6 vs 49.2), and health utilities (0.71 vs 0.75) than adults without COPD. Workers 
with COPD reported significantly greater presenteeism (18.9% vs 14.3%), overall work impair-
ment (20.5% vs 16.3%), and impairment in daily activities (23.5% vs 17.9%) than adults without 
COPD. Employed adults with COPD also reported more mean emergency room visits (0.21 vs 
0.12) and more mean hospitalizations (0.10 vs 0.06) in the previous 6 months than employed 
adults without COPD. All of the above differences were significant at two-sided P , 0.05.
Conclusion: After adjusting for various confounders, employed adults with COPD reported 
significantly lower quality of life and work productivity, and increased health care resource 
utilization than employed adults without COPD. These results highlight the substantial impact 
and burden of COPD in the United States workforce.
Keywords: chronic obstructive pulmonary disease, quality of life, work productivity, activities 
of daily living, health care resource use
Introduction
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in 
the United States.1 Although it has been diagnosed in more than 10 million people, as 
many as 24 million may have airflow limitation consistent with COPD.1 Historically, 
measures of pulmonary function, such as the forced expiratory volume in 1 second 
test, have been the standard markers for physiological change in COPD, but have only 
been weakly associated with dyspnea (shortness of breath) and other symptoms.2 Thus, 
patient-reported outcomes such as health-related quality of life (HRQoL) and work 
productivity have become important measures in COPD therapy.3
In an effort to improve COPD management, much research has focused on the 
complex interrelationships between the HRQoL of COPD patients and the   determining 
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factors thereof. Age, gender, disease severity, smoking, 
socioeconomic status, and psychological factors have been 
studied in detail, even if little agreement about their effects 
on HRQoL has been made.4–8 However, few studies have 
examined the impact of COPD among the US workforce. 
Previous   studies have shown that the diagnosis of COPD was 
associated with a reduction in workforce participation and 
disability.9,10 Among those patients who are able to maintain 
their place in the workforce, however, the extent of COPD 
burden is unclear. While some studies have investigated the 
impact of the disease on absenteeism (time missed from 
work), research on the subtle effects of presenteeism (lost 
productivity while at work) have largely been neglected.11
Although resource use has been documented among 
younger employees diagnosed with COPD,12 studies typi-
cally did not assess self-reported health care utilization.   
An approach from the employee perspective could comple-
ment this literature, especially when comparing resource 
use of COPD workers to controls. The aim of this study is to 
assess the impact of COPD on HRQoL, work productivity, 
and resource use among employed adults.
Methods
Sample
Data were obtained from 75,000 respondents who completed 
the 2009 US National Health and Wellness Survey (NHWS), 
an annual, cross-sectional study of patients aged 18 years or 
older. The self-administered, Internet-based questionnaire 
was given to a sample population identified through   
a web-based consumer panel whose members were recruited 
through opt-in emails, co-registration with panel partners, 
e-newsletter campaigns, online banner placements, and 
both internal and external affiliate networks. All panelists 
explicitly agreed to become panel members, registered 
through unique email addresses, and completed in-depth 
demographic registration profiles. A stratified random 
sampling procedure was implemented, using strata based 
on gender, age, and race/ethnicity, in order for the sample 
to be representative of the demographic composition of the 
general population. The study was approved by the Essex 
Institutional Review Board.
Of the 501,239 who were contacted, 92,759 responded 
(an 18.5% response rate). Of those who responded, 75,000 
gave their informed consent, met the inclusion criteria (aged 
18 years or over), and completed the survey instrument. 
The demographic composition of the US NHWS sample is 
comparable to that of the US adult population as assessed 
by the Current Population Survey of the US Census Bureau 
and prevalence estimates of various conditions from NHWS 
are consistent with other well-established sources such as 
the National Health Interview Survey.13 In the current study, 
data were analyzed only for workers (full-time employed, 
part-time employed, or self-employed) aged 40–64 years 
(n = 20,024).
Measures
COPD diagnosis
All NHWS respondents were asked a series of questions 
regarding conditions they might have previously experienced. 
Those who self-reported experiencing chronic bronchitis, 
emphysema, or COPD in the past were then asked whether 
their condition had been diagnosed by a physician. Those who 
self-reported a diagnosis of COPD, who were 40–64 years 
of age and employed (full-time, part-time, or self-employed) 
were compared with those not diagnosed with COPD, who 
were 40–64 years of age and employed (see Figure 1).   
No other information (clinical or otherwise) was used to 
define the groups.
Demographics
Data on each worker’s age, gender, race/ethnicity (non-
Hispanic white, non-Hispanic black/African-American, 
Hispanic, or other), highest educational level attained   (college 
degree or more vs less than college degree), previous year’s 
household income (,$25,000, $25,000 to ,$50,000, $50,000 
to ,$75,000, $75,000 or more, or decline to answer), health 
insurance (yes vs no), health insurance with prescription 
coverage (yes vs no), and type of employment (full-time, 
part-time, or self-employed) were assessed.
Health history
Workers also provided data on their body mass index 
(BMI) level (categorized by reported weight and height: 
underweight (,18.5), normal (18.5–24.9), overweight 
(25.0–29.9), obese ($30), and missing BMI information,   
smoking status (current smoker, former smoker, or never 
smoker), exercise behavior (exercised in the past month vs 
not exercised in the past month), and alcohol use (current 
drinker vs non-drinker). Self-reported diagnosis of asthma 
and the estimation of the Charlson comorbidity index (CCI) 
were also measured. The CCI captures the extent of comorbid 
burden and is calculated by weighting the presence of the 
following conditions and summing the result: HIV/AIDS, 
metastatic tumor, lymphoma, leukemia, any tumor, moderate/
severe renal disease, hemiplegia, diabetes, mild liver disease, 
ulcer disease, connective tissue disease, chronic pulmonary 
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  disease,   dementia, cerebrovascular disease, peripheral 
  vascular disease,   myocardial infarction, and congestive heart 
failure (note that the adjusted CCI does not include diabetes 
with end organ damage and moderate/severe liver disease 
which appears in the original CCI; otherwise the calculations 
are identical to the original algorithm).
HRQoL
HRQoL was assessed using the SF-12v2, a generic HRQoL 
instrument which includes twelve items.14 The SF-12v2 instru-
ment has an extensive body of literature to support its validity 
and reliability.14 The mental component summary and physical 
component summary scores were used in the current study. 
These summary scores are normed to the US population and 
have a mean of 50 and a standard deviation of 10. Health state 
utilities, preference-based single index measures of health, 
were also calculated from the SF-12 items, and included as the 
SF-6D. Utility scores vary from 0 (death) to 1 (full health).
Work productivity and activity impairment
Work productivity and impairment were assessed using 
the Work Productivity and Activity Impairment Questionnaire: 
General Health.15 Derived from the questionnaire were four 
metrics: absenteeism (the percentage of work time missed due 
to health in the past 7 days), presenteeism (the percentage of 
impairment while at work due to health in the past 7 days), 
overall work loss (the total percentage of missed time due 
to absenteeism and presenteeism in the past 7 days), and 
activity impairment (the percentage of impairment suffered 
during daily activities in the past 7 days). Each metric   varies 
from 0% to 100% with higher scores indicating greater 
impairment.
Absenteeism is calculated by dividing the number of 
work hours a worker missed in the past week because of their 
health by the total number of hours they could have worked 
(the number of hours they did work plus the number of hours 
they missed because of their health), then converting this 
proportion into a percentage. Presenteeism was measured by 
a worker’s reported level of impairment experienced while at 
work in the past 7 days (from 0 to 10), which was then multi-
plied by ten to create a percentage. Overall work impairment 
was measured by combining absenteeism and presenteeism. 
Activity impairment was measured by a worker’s response 
to their level of impairment experienced in daily activities 
in the past 7 days (from 0 to 10), which was then multiplied 
by ten to create a percentage.
The Work Productivity and Activity Impairment 
Questionnaire: General Health has been found to have 
adequate reliability and validity.15 The scale has also been 
used in a variety of disease areas including asthma16 and has 
been used to measure differences in those with and without 
particular diseases to assess burden of illness.13,17,18
Invited to participate in NHWS 
survey 
n = 501,239
Responders 
n = 92,759
Eligible respondersa
n = 75,000
Aged 40–64 years 
n = 24,567
Currently employed 
n = 20,024
Non-responders 
n = 408,480
Ineligible responders 
n = 17,759
Aged 18–39 or 65+ years
n = 50,433
Not diagnosed with COPD
n = 18,912
Diagnosed with COPD
n = 1112
Not currently employed 
n = 4543
Figure 1 Inclusion and exclusion flow chart.
Note: aEligible responders included those who provided informed consent, were aged 18 years and over, and completed the survey instrument.
Abbreviations: NHWS, National Health and Wellness Survey; COPD, chronic obstructive pulmonary disease.
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Health care resource use
Health care utilization was defined by traditional health care 
providers such as general practitioners and internists (“which 
of the following traditional health care providers have you 
seen in the past 6 months?”). Additionally, the number of 
traditional health care visits, the number of emergency 
room (ER) visits (“how many times have you been to the 
ER for your own medical condition in the past 6 months?”), 
and the number of times hospitalized in the past 6 months 
(“how many times have you been hospitalized for your own 
medical condition in the past 6 months?”) were included in 
the analyses.
Analyses
Univariate analyses were conducted on all workers in order 
to fully describe the sample demographically. Weights 
(based on 2008 March Current Population Survey) were 
then applied to the sample to project to the US population. 
Using the   chi-square and t-tests for categorical and continu-
ous variables, respectively, and Wilcoxon–Mann–Whitney 
tests for continuous non-normal variables differences 
between those diagnosed with COPD, employed, aged 40–64 
years and those not diagnosed with COPD, employed, aged 
40–64 years were examined on demographic and health 
history variables.
Multivariable regression analyses were performed to 
determine whether the COPD group differed from the 
control group on HRQoL, work productivity, and resource 
use after adjusting for demographic (reference categories: 
male, full-time employed, white, single, college educated, 
income of less than $25,000, no health insurance) and 
health history variables (reference categories: not diag-
nosed with asthma, normal weight, never smoked). Our 
statistical approach varied depending upon the nature of 
the dependent   variable. Multiple regressions were used 
for HRQoL variables since the SF-12v2 is normed, and 
generalized linear models (specifying a negative binomial 
distribution and a log-link function) were used for work 
productivity and resource utilization, to adjust for non-
normality in the Work   Productivity and Activity Impair-
ment Questionnaire:   General Health scores and resource 
use variables. The estimates based on the generalized 
linear models (work productivity and resource utilization) 
represent changes in adjusted log values in the given out-
come, rather than adjusted values in the outcome, itself. 
Logistic regressions were used to predict the presence 
or absence of traditional and non-traditional health care 
provider visits. All analyses were conducted using SAS 
(v 9.1; SAS Institute Inc, Cary, NC) and a two-tailed 
threshold of P , 0.05 was specified to determine statisti-
cal significance.
Results
Univariate analyses
A total of 20,024 workers were employed and aged 
40–64 years. Of those, 1112 were diagnosed with COPD 
and 18,912 were not diagnosed with COPD. Among those 
employed, most were male (53.4%), non-Hispanic white 
(70.3%), married or living with a partner (65.7%), and had 
received a college education (81.3%). Most workers were 
employed full-time (70.3%).
Unadjusted comparisons
Workers with COPD were significantly less likely to be 
male (45.54% vs 53.89%, P , 0.0001), non-Hispanic black/
African-American (8.75% vs 11.57%, P = 0.0012),   Hispanic 
(8.52% vs 12.24%, P = 0.0008), full-time employed (64.65% 
vs 70.60%, P , 0.0001), of normal weight (21.05% vs 25.59%, 
P = 0.0005), overweight (30.10% vs 35.91%, P = 0.0004), to 
have missing BMI information (1.21% vs 1.95%, P = 0.0458), 
and to have a household income of $75,000 or more per year 
(26.59% vs 34.42%, P , 0.0001).
Workers with COPD were significantly more likely to 
be non-Hispanic white (76.45% vs 69.96%, P , 0.0001) or 
other race/ethnicity (5.04% vs 2.62%, P = 0.0103), part-time 
employed (16.13% vs 13.13%, P = 0.0091), self-employed 
(19.22% vs 16.27%, P = 0.0174), diagnosed with asthma 
(28.00% vs 6.23%, P , 0.0001), obese (46.01% vs 36.18%, 
P , 0.0001), have a household income of less than $25,000 
per year (13.55% vs 10.00%, P = 0.001), and have a house-
hold income of $25,000 to $49,999 per year (33.20% vs 
27.16%, P , 0.0001). COPD workers reported significantly 
worse health outcomes than non-COPD workers as captured 
by HRQoL, work productivity, and health care resource use 
(see Table 1).
Multivariable analyses with adjustments
After adjusting for demographic and health history vari-
ables, a number of outcome measures were significantly 
associated with COPD diagnosis. Workers with COPD 
had significantly lower levels of mental component sum-
mary (adjusted means: COPD = 46.76 vs control = 48.51, 
P , 0.0001), physical component summary (adjusted 
means: COPD = 45.64 vs   control = 49.23, P , 0.0001), 
and health utility scores (adjusted means: COPD = 0.71 vs 
control = 0.75, P , 0.0001) (see Figure 2).
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Figure 3 Mean levels of work productivity and activity impairment after adjusting for demographics and patient characteristics (comparing workers with COPD versus those 
without).
Note: Differences in presenteeism, overall work impairment, and activity impairment were found to be statistically significant (P , 0.0001).
Abbreviation: COPD, chronic obstructive pulmonary disease.
Although there were no significant differences between 
the groups in regard to absenteeism (adjusted means: 
COPD = 3.60% vs control = 3.42%, P = 0.7180), workers 
with COPD reported significantly higher levels of presentee-
ism (adjusted means: COPD = 19.28% vs control = 14.59%, 
P , 0.0001; see Figure 3). The composite overall work loss 
metric was also significantly different between the cohorts 
(adjusted means: COPD = 20.93% vs control = 16.59%). 
Activity impairment, or lost productivity outside of work, 
was also significantly higher among those who reported 
a COPD diagnosis (adjusted means: COPD = 23.95% vs 
control = 18.23%, P , 0.0001).
COPD workers reported a significantly higher num-
ber of ER visits in the past 6 months (adjusted means: 
COPD = 0.22 vs control = 0.12, P , 0.0001), hospitalizations 
(adjusted means: COPD = 0.11 vs control = 0.06, 
P , 0.0001) in the past 6 months (see   Figure 4), odds of 
visiting a traditional health care provider (odds ratio = 0.69, 
P = 0.0008), and odds of visiting a non-traditional 
health care provider (b = 1.167, P = 0.0401). However, 
no   significant differences were found in the number of 
traditional health care provider visits (adjusted means: 
COPD = 3.33 vs control = 3.06).
Discussion
Although previous studies have examined the impact of 
COPD on patient-reported outcomes, few studies have 
focused exclusively on the workforce. Further, prior research 
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Figure 2 Mean levels of quality of life components after adjusting for patient demographic and patient characteristics (comparing workers with COPD versus those without).
Note: Differences in MCS and PCS were found to be statistically significant (P , 0.0001).
Abbreviations: COPD, chronic obstructive pulmonary disease; MCS, mental component summary score; PCS, physical component summary score.
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has often grouped older and younger workers together,4 so 
that limiting the analyses to those aged 40–64 years helps 
homogenize the sample and isolates those in their peak earn-
ing years. This focus is also helpful in that most HRQoL 
studies have ignored those under the age of 65 years with 
COPD.4–7,19,20
The results of the current study suggest that workers diag-
nosed with COPD have significantly lower levels of HRQoL, 
even after controlling for health history and comorbidities.   
It is important to note that previous studies have often com-
pared COPD workers to population norms (mean = 50, stan-
dard deviation = 10), without direct comparisons with control 
cohorts.5,6 Using such a direct comparison further emphasizes 
the impact that COPD can have on humanistic outcomes.
Previous studies have found COPD to be associated with 
reductions in workforce participation9,21 and increases in 
absenteeism.11 Although a trend toward greater absenteeism 
was observed here, it was not significant. However, significant 
differences between the COPD group and the control group 
were observed on presenteeism, a finding not previously 
reported. This result is important to emphasize because the 
effects of COPD may go unnoticed by employers who may 
focus on work absences rather than lost productivity while 
at work. Additionally, overall work impairment and activ-
ity impairment were also significantly higher among those 
diagnosed with COPD.
Lastly, health care resource utilization was significantly 
associated with COPD diagnosis. After accounting for 
demographic and health history variables, COPD workers 
were more likely to visit a traditional and non-traditional 
health care provider, but COPD workers did not report a 
higher number of traditional provider visits. COPD workers 
did, however, report significantly more ER visits and hos-
pitalizations relative to controls. It is possible that the lack 
of additional provider visits may account for some of the 
humanistic and productivity loss detriments. Perhaps a lack of 
active management was a reason for poor outcomes and may 
explain higher rates of ER visits and   hospitalizations. Future 
research is clearly necessary to examine these hypotheses.
Limitations
Because the NHWS is a cross-sectional survey, all relation-
ships can only be expressed as associations and not causal 
relationships. Further research employing prospective and 
longitudinal designs may be useful in corroborating the 
burden of COPD as observed here, particularly as it relates 
to resource use. It is also important to note, though every 
attempt was made to rule out alternative explanations, that 
unmeasured variables may explain the relationships between 
group membership and health outcomes. Because of the self-
reported nature, recall bias may have introduced additional 
error into the observed associations. Some patients may have 
incorrectly reported a COPD diagnosis when they do not 
have COPD and some patients may have failed to report a 
COPD diagnosis when they have COPD. Finally, although the 
NHWS is demographically representative of the US popula-
tion because of the random stratified sampling framework, 
the final sample may differ in meaningful ways other than 
demographics, which could affect the size and direction of the 
relationships observed here. In other words, those who chose 
to respond to the survey may differ from those who chose not 
to respond (eg, health status, health care attitudes, etc) and   
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Figure 4 Mean levels of resource use after adjusting for demographics and patient characteristics (comparing workers with COPD versus those without).
Note: Differences in ER visits, hospitalizations, and provider visits were found to be statistically significant (P , 0.0001).
Abbreviations: COPD, chronic obstructive pulmonary disease; ER, emergency room.
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these factors could artificially inflate or deflate the   differences 
between groups.
Conclusion
Workers diagnosed with COPD reported significantly lower 
levels of HRQoL and higher levels of presenteeism, over-
all work impairment, activity impairment, ER visits, and 
  hospitalizations. These effects remained even after adjusting 
for differences between the COPD group and control group 
in terms of comorbidities and other health history variables. 
Though absenteeism rates were similar between the two groups, 
employers should be aware that productivity losses were signifi-
cantly higher among COPD workers as were costly ER visits 
and hospitalizations. Effective programs and policies may be 
necessary to better manage COPD workers in the workforce.
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